Rajendran, Luckshi
Choi, Woo Jin
Muaddi, Hala
Ivanics, Tommy
Feld, Jordan J.
Claasen, Marco P. A. W.
Castelo, Matthew
Sapisochin, Gonzalo
Article History
Received: 12 September 2022
Accepted: 21 November 2022
First Online: 14 December 2022
DISCLOSURES
: Gonzalo Sapisochin discloses consultancy for Astra-Zeneca, Roche, Novartis, and Integra. Gonzalo Sapisochin has received financial compensation for talks for Roche, Astra-Zeneca, Chiesi, Evidera and Integra. Gonzalo Sapisochin has received a grant from Roche. Jordan Feld discloses research support from Abbvie, Gilead, GSK, Janssen, Eiger, Enanta, and Roche and consulting for Abbvie, GSK, Gilead, Roche. None of the other authors have any conflicts of interest to declare.